Work

Updates on in vitro maturation technology in human immature oocytes for clinical application

Year: 2025

Type: article

Abstract: Recent progress in in vitro maturation (IVM) technology using human immature oocytes for clinical applications has been reported. The success rate of IVM technology depends on the source of immature oocytes, and to date, no single protocol has demonstrated superior results over others. Attempts to adapt IVM protocols developed in animal models have not let to significant breakthroughs in culture conditions and systems. Cumulus cells are known to play an important role in oocyte maturation; however, the results of co-culture with different types of cells for IVM of human immature oocytes remain controversial. As one of the assisted reproductive technologies (ART), IVM is only involved in a specific procedure for infertility treatment and fertility preservation. With the development of IVM technology, it has been proposed that the combination of mild-stimulation cycle with retrieval of both mature and immature oocytes, followed by IVM, may offer a viable alternative to the conventional stimulation cycle treatment.

Source: Reproductive and Developmental Medicine

DOI: 10.1097/rd9.0000000000000145

Authors: Ri-Cheng Chian, Guan Wang, Dong-Mei Zhang, Mei Shan, Ying Wei, Yong-Qing Zhu, Cong-Jian Xu

Institutions: Shanghai Medical College of Fudan University, Fudan University, Heilongjiang Provincial Hospital, Obstetrics and Gynecology Hospital of Fudan University, Affiliated Hangzhou First People's Hospital, Westlake University, School of Medicine

Language: English

Topic: Reproductive Biology and Fertility

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W4416714666

FWCI:

Cites: 46

Cited by:

Related to: